2018
DOI: 10.3389/fimmu.2017.01955
|View full text |Cite
|
Sign up to set email alerts
|

The Role of Skin and Orogenital Microbiota in Protective Immunity and Chronic Immune-Mediated Inflammatory Disease

Abstract: The skin and orogenital mucosae, which constitute complex protective barriers against infection and injuries, are not only the first to come into contact with pathogens but are also colonized by a set of microorganisms that are essential to maintain a healthy physiological environment. Using 16S ribosomal RNA metagenomic sequencing, scientists recognized that the microorganism colonization has greater diversity and variability than previously assumed. These microorganisms, such as commensal bacteria, affect th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
32
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
3
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 48 publications
(38 citation statements)
references
References 116 publications
0
32
0
1
Order By: Relevance
“…In the case of SBT products, they have applications in the supportive therapy of local skin lesions, mucosal infections, and associated inflammatory symptoms in wound healing and other conditions [ 8 , 9 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 ], directions that are in part reflected in the topics of ongoing clinical trials [ 10 ]. However, the sites of possible action of SBT-derived compounds in human body are the niches richly inhabited by many microorganisms constituting natural microbiota, which play a significant role in the host immune system [ 19 , 20 ]. Therefore, the influence of fractionated SBT extracts has been tested on representatives of pathogenic, opportunistic, and commensal microorganisms of the following genera: Staphylococcus , Streptococcus , Helicobacter , Bacillus , Escherichia , Proteus , Pseudomonas , Lactobacillus , Candida .…”
Section: Resultsmentioning
confidence: 99%
“…In the case of SBT products, they have applications in the supportive therapy of local skin lesions, mucosal infections, and associated inflammatory symptoms in wound healing and other conditions [ 8 , 9 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 ], directions that are in part reflected in the topics of ongoing clinical trials [ 10 ]. However, the sites of possible action of SBT-derived compounds in human body are the niches richly inhabited by many microorganisms constituting natural microbiota, which play a significant role in the host immune system [ 19 , 20 ]. Therefore, the influence of fractionated SBT extracts has been tested on representatives of pathogenic, opportunistic, and commensal microorganisms of the following genera: Staphylococcus , Streptococcus , Helicobacter , Bacillus , Escherichia , Proteus , Pseudomonas , Lactobacillus , Candida .…”
Section: Resultsmentioning
confidence: 99%
“…47 During puberty, new changes occur in skin microbiota. 48 There are several mechanisms by which changes in microbial skin diversity (dysbiosis) affect the development of atopic dermatitis; the production, by these dysbiosis bacteria, of several enzymes, such as: proteases (which induce corneocyte desquamation); lipases (which break down lipids of skin barrier); ceramidases (which break down the ceramides present in the barrier structure). 49,50 This bacterial overgrowth, with subsequent biofilm formation and mainly related to the pathogenic strains of Staphylococcus aureus (methicillin-resistant Staphylococcus aureus), would be directly related to changes in the cutaneous barrier.…”
Section: Does the Cutaneous Microbiota Influence The Control Of Atopimentioning
confidence: 99%
“…Once in the dermis, these commensals initiate a vigorous host inflammatory response. For unknown genetic, hormonal, and/or environmental reasons, these commensal bacteria could multiply and become pathogenic (Park and Lee, 2017).…”
Section: Reconciling the Potential Roles Of Bacteria In Hsmentioning
confidence: 99%